Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
Not Confirmed
Not Confirmed
03-05 June, 2026
Peptide Therapeutics F...Peptide Therapeutics Forum 2026
Not Confirmed
Not Confirmed
04-05 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
Industry Trade Show
Not Confirmed
03-05 June, 2026
Peptide Therapeutics F...Peptide Therapeutics Forum 2026
Industry Trade Show
Not Confirmed
04-05 June, 2026
Digital content

28 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/28/3302500/0/en/veraxa-biotech-strengthens-financial-position-with-27-5-million-principal-amount-senior-secured-note-financing-and-50-million-share-purchase-agreement.html

02 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/02/3247012/0/en/VERAXA-Biotech-Shareholders-Approve-Merger-and-Issuance-of-New-Shares-to-Voyager-Acquisition-Corp.html

30 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/30/3158495/0/en/VERAXA-Biotech-and-Secarna-Pharmaceuticals-Initiate-Antibody-Oligonucleotide-Conjugate-Alliance-in-Immunology.html

17 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/17/3116951/0/en/VERAXA-Biotech-and-Voyager-Acquisition-Corp-Announce-Filing-of-Form-F-4-Registration-Statement-with-the-SEC.html

29 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/29/3090517/0/en/VERAXA-Biotech-to-Attend-Key-Industry-Conferences-to-Showcase-BiTAC-Technology-Platform.html

20 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/20/3084508/0/en/VERAXA-Biotech-Appoints-Rick-Austin-as-Chief-Scientific-Officer.html
ABOUT THIS PAGE